Algernon Pharmaceuticals Inc (AGN.CX)
0.14
0.00 (0.00%)
CAD |
CNSX |
May 17, 15:59
Algernon Pharmaceuticals Cash from Investing (TTM): -0.1223M for Nov. 30, 2022
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| November 30, 2022 | -0.1223M |
| August 31, 2022 | -0.1446M |
| May 31, 2022 | -0.1059M |
| February 28, 2022 | -0.1778M |
| November 30, 2021 | -0.1582M |
| August 31, 2021 | -0.1244M |
| May 31, 2021 | -0.1397M |
| February 28, 2021 | -0.1098M |
| November 30, 2020 | -0.094M |
| August 31, 2020 | -0.0997M |
| May 31, 2020 | -0.0758M |
| February 29, 2020 | -0.0797M |
| November 30, 2019 | -0.0777M |
| Date | Value |
|---|---|
| August 31, 2019 | 0.0902M |
| May 31, 2019 | 0.0919M |
| February 28, 2019 | 0.1485M |
| November 30, 2018 | 0.1559M |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.1091M |
| February 28, 2018 | -0.0244M |
| November 30, 2017 | -0.0041M |
| August 31, 2017 | -0.0603M |
| May 31, 2017 | 0.0016M |
| February 28, 2017 | 0.0378M |
| November 30, 2016 | -0.0135M |
| August 31, 2016 | 1.414M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.1778M
Minimum
Feb 2022
0.0919M
Maximum
May 2019
-0.0885M
Average
-0.1059M
Median
May 2022